Inventor
ARIAANS GERARDUS JOSEPH ANDREAS
NL8 patents
⚠️ This page may combine multiple inventors who share the name “ARIAANS GERARDUS JOSEPH ANDREAS”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SYNTHON BIOPHARMACEUTICALS BV
4 patentsUS10407743B2Sep 10, 2019
Site-specific conjugation of linker drugs to antibodies and resulting ADCs
SYNTHON BIOPHARMACEUTICALS BV4 citations82
US9580501B2Feb 28, 2017
Anti-TNF alpha monoclonal secretory IgA antibodies and methods for treating inflammatory diseases
SYNTHON BIOPHARMACEUTICALS BV5 citations79
US9573996B2Feb 21, 2017
Monoclonal antibodies to human proinflammatory cytokines and methods for treating inflammatory diseases
SYNTHON BIOPHARMACEUTICALS BV6 citations79
US11136633B2Oct 5, 2021
Site-specific conjugation of linker drugs to antibodies and resulting ADCS
SYNTHON BIOPHARMACEUTICALS BV2 citations71
BYONDIS BV
4 patentsUS11104968B2Aug 31, 2021
Site-specific conjugation of linker drugs to antibodies and resulting ADCS
BYONDIS BV2 citations71
US11584801B2Feb 21, 2023
Anti-5T4 antibodies and antibody-drug conjugates
BYONDIS BV2 citations66
US11008400B2May 18, 2021
Anti-5T4 antibodies and antibody-drug conjugates
BYONDIS BV5 citations66
US12180552B2Dec 31, 2024
Site-specific conjugation of linker drugs to antibodies and resulting ADCs
BYONDIS BV0 citations60